Prosperity Consulting Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
18,961
-1,020
-5% -$82.3K 0.06% 208
2026
Q1
$1.73M Sell
19,981
-2,050
-9% -$196K 0.08% 171
2025
Q4
$2.12M Buy
22,031
+2,712
+14% +$263K 0.1% 153
2025
Q3
$1.84M Sell
19,319
-163
-0.8% -$15K 0.09% 177
2025
Q2
$1.7M Sell
19,482
-518
-3% -$43.9K 0.12% 161
2025
Q1
$1.8M Buy
20,000
+257
+1% +$23K 0.14% 158
2024
Q4
$1.58M Sell
19,743
-3,735
-16% -$323K 0.12% 170
2024
Q3
$2.11M Sell
23,478
-7,022
-23% -$591K 0.16% 143
2024
Q2
$2.4M Sell
30,500
-17,513
-36% -$1.44M 0.33% 79
2024
Q1
$4.18M Buy
48,013
+44,092
+1,125% +$3.76M 0.52% 52
2023
Q4
$323K Buy
3,921
+1,087
+38% +$82.8K 0.11% 152
2023
Q3
$222K Buy
+2,834
New +$237K 0.1% 133

Other funds holding MDT

Prosperity Consulting Group's MDT Position: Q2 2026 in Review

Prosperity Consulting Group reduced its Medtronic (MDT) stake by 5.1% in Q2 2026, selling an estimated $82.3K and leaving 18,961 shares worth $1.48M. The position accounts for 0.06% of the portfolio, ranked #208.

Prosperity Consulting Group first reported a position in MDT in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.18M in Q1 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Prosperity Consulting Group held 18,961 shares of Medtronic worth $1.48M as of Q2 2026.
  • Prosperity Consulting Group sold 1,020 Medtronic shares in Q2 2026, an estimated $82.3K.
  • Medtronic made up 0.06% of Prosperity Consulting Group's portfolio in Q2 2026, its #208 holding.
  • Prosperity Consulting Group first reported a position in Medtronic in Q3 2023 and has held it in 12 quarters since.
  • Prosperity Consulting Group's Medtronic position peaked at $4.18M in Q1 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.